Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
Published October 28, 2026 · Recall initiated: October 6, 2026
Summary
FDA records drug Class II recall D-0076-2027, published October 28, 2026 and initiated October 6, 2026. Recalling firm: Hikma Pharmaceuticals USA INC.; Status: Ongoing; Reported quantity: 2136 bottles; Lot: Lot #: 3047, Exp Date July 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
What to do
Voluntary: Firm initiated · Letter
Get an email if ABIRTEGA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ABIRTEGA
- Manufacturer
- Hikma Pharmaceuticals USA INC.
- Distributor
- Nationwide within the United States
- UPC
- 0382249011123
- Lot
- Lot #: 3047, Exp Date July 2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials (NDC 73271-1225-1) and b) 30 m vials ( NDCOctober 28, 2026
- FDACinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry,October 28, 2026
- FDAARU, Toothpaste, Cavity Protection, 9 Ingredients, Cool Mint, (sodium fluoride 0.243%) Net Wt 3.5 oz (99g),October 28, 2026
- FDAArgatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for:October 28, 2026
- FDAARU, Toothpaste, Gum Health, 9 Ingredients, Soothing Mint, (stannous fluoride 0.45%) Net Wt 3.5 oz (99g),October 28, 2026
- FDAArgatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for:October 28, 2026
Questions about this recall
Was Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12. recalled?
Yes. FDA published recall D-0076-2027 on October 28, 2026. Reported hazard: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ABIRTEGA. UPC: 0382249011123.